BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 25, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

July 28, 2020

View Archived Issues
Brain-keyhole-landscape.png

Alzheimer’s blood test could improve trials, help find treatments

CYBERSPACE – Data presented at the virtual 2020 Alzheimer's Association International Conference (AAIC) and reported in the July 28, 2020, online issue of the Journal of the American Medical Association (JAMA) demonstrated that blood levels of phosphorylated tau-217 (Ptau-217) did as well as cerebrospinal (CSF)- and PET-based biomarkers, and significantly better than other blood-based biomarkers, at discriminating individuals with Alzheimer’s disease (AD) from those with other neurodegenerative disorders. Read More
US-Washington-congress-senate-house.png

Senate hearing highlights need to shift pandemic-related supply chains away from China

The U.S. Senate Finance Committee held the first of its two hearings on the supply chains for a variety of products vital to the response to the COVID-19 pandemic. While electoral politics were on full display during the hearing, a recurrent theme was the need to bring supply chains back to the Western Hemisphere as a solution to the fraudulent products shipped to the U.S. from Hong Kong and China. Read More
3D Euro symbol

Indigo gets $44.5M series B round for long-lasting, undetectable diabetes CGM implant

Indigo Diabetes NV is working to develop a next-generation continuous glucose monitor (CGM) that would be much simpler and easier to use routinely, potentially making it more useful for a much larger population. It has just raised a €38 million ($44.5 million) series B financing to support that effort. Read More
business-performance-pipeline.png

Labcorp beats Q2 estimates with strong COVID-19 testing

Diagnostics testing company Laboratory Corp. of America Holdings Inc. (Labcorp) saw its second-quarter revenue decline by 4% to $2.8 billion, but that still beat the Street consensus of $2.5 billion. Diagnostics revenue fell 3.9% year over year to $1.7 billion, but that was offset by solid demand for the company’s COVID-19 tests. Read More
Genexus system

Thermo Fisher subsidizes Genexus systems for oncology labs

Thermo Fisher Scientific expanded its Globalaccess Sequencing Program to include oncology laboratories in addition to research labs working on COVID-19 studies. The company will subsidize a limited number of Genexus systems to help pathology laboratories around the world. Read More

Starvation safety switch could make cell therapies safer

By deleting the gene for uridine monophosphate synthetase (UMPS), an enzyme in the pathway for uridine synthesis, researchers have made cells, including embryonic stem cells and T cells, dependent on dietary uridine. The work, which was published in the July 13, 2020, online issue of Nature Biotechnology, adds a new potential way of controlling cell therapies. Read More

Appointments and advancements for July 28, 2020

New hires and promotions in the med-tech industry, including: Clinical Genomics, Covera Health, Experion Holdings, Meridian Bioscience, Mimedx Group, Phreesia, Sensus Healthcare, Tecan Group, Varex Imaging. Read More

Financings for July 28, 2020

Med-tech firms raising money in public or private financings, including: Bioaffinity Technologies, Nano-X Imaging, Nemaura Medical, Sequana Medical. Read More

In the clinic for July 28, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ibex, Ortho Regenerative Technologies. Read More

Other news to note for July 28, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aegea Biotechnologies, Aminoverse, Bioivt, Ciox Health, Cytosorbents, Datos Health, Edifecs, Exagen, Guided Therapeutics, Heart Health Intelligence, Hims & Hers, Ireceptor Plus, Medal, Midwest Institute for Minimally Invasive Therapies, Neuroone Medical Technologies, Orbis Diagnostics, Osi Systems, Saykara, Tauriga Sciences, Truework, Tscan, Twist Bioscience, Vaica Medical. Read More

Regulatory actions for July 28, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neocis, Nowdiagnostics. Read More

Regulatory front for July 28, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies. Read More

BioWorld MedTech’s Oncology Extra for July 28, 2020

Keeping you up to date on recent developments in oncology, including: ctDNA associated with poor outcomes in triple-negative breast cancer; Protons beat IMRT for locally advanced esophageal cancer; Study affirms cancer patients avoiding clinical care. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Brain and DNA

    Sangamo presents primate data for prion suppressor ST-506

    BioWorld Science
    Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
  • TREM2 agonists detailed in Pfizer patent

    BioWorld Science
    Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
  • Roche reports new TREM2 agonists

    BioWorld Science
    F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing